Evidence That the Wiskott-Aldrich Syndrome Protein May Be Involved in Lymphoid Cell Signaling Pathways

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 3791-3795

  Cory, Giles O C ^a   MacCarthy Morrogh, Lucy ^a   Banin, Sharon ^b   Gout, Ivan ^c   Brickell, Paul M ^b   Levinsky, Roland J ^a   Kinnon, Christine ^a   Lovering, Ruth C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; PEPTIDE FRAGMENT; PROLINE; PROTEIN; PROTEIN TYROSINE KINASE; WAS PROTEIN, HUMAN; WISKOTT ALDRICH SYNDROME PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; BINDING SITE; BURKITT LYMPHOMA; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CHEMISTRY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; PROTEIN BINDING; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; WISKOTT ALDRICH SYNDROME;

AMINO ACID SEQUENCE; B-LYMPHOCYTES; BINDING SITES; BURKITT LYMPHOMA; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; GENE EXPRESSION; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROLINE; PROTEIN BINDING; PROTEINS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES; TUMOR CELLS, CULTURED; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 0030292702     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Derry, J. M. J., J. A. Kerns, K. I. Weinberg, H. D. Ochs, V. Volpini, X. Estivill, A. P. Walker, and U. Francke. 1995. WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum. Mol. Genet. 4:1127.
2. Blease, R. M., W. Strober, R. S. Brown, and T. A. Waldmann. 1968. The Wiskott-Aldrich syndrome: a disorder with a possible defect in antigen processing or recognition. Lancet 1:1056.
3. Molina, I. J., J. Sancho, C. Terhorst, F. S. Rosen, and E. Remold-O'Donnell. 1993. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J. Immunol. 151:4383.
4. Yu, H., J. K. Chen, S. Feng, D. C. Dalgarno, A. W. Brauer, and S. L. Schreiber. 1994. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76:933.
5. Rivero-Lezcano, O. M., A. Marcilla, J. H. Sameshima, and K. C. Robbins. 1995. Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol. Cell. Biol. 15:5725.
6. Vetrie, D., I. Vorechovsky, P. Sideras, J. Holland, A. Davies, F. Flinter, L. Hammarström, C. Kinnon, R. Levinsky, M. Bobrow, C. I. E. Smith, and D. R. Bentley. 1993. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein tyrosine kinases. Nature 361:226.
7. Conley, M. E. 1985. B cells in patients with X-linked agammaglobulinemia. J. Immunol. 134:3070.
8. Milili, M., F. Le Deist, G. de Saint Basile, A. Fischer, M. Fougereau, and C. Schiff. 1993. Bone marrow cells in X-linked agammaglobulinemia express pre-B-specific genes (lambda-like and V pre-B) and present immunoglobulin V-D-J gene usage strongly biased to a fetal-like repertoire. J. Clin. Invest. 91: 1616.
9. Genevier, H. C., S. Hinshelwood, H. B. Gaspar, K. P. Rigley, D. Brown, S. Saeland, F. Rousset, R. J. Levinsky, R. E. Callard, C. Kinnon, and R. C. Lovering. 1994. Expression of Bruton's tyrosine kinase protein within the B cell lineage. Eur. J. Immunol. 24:3100.
10. Smith, C. I. E., B. Baskin, P. Humire-Greiff, J.-N. Zhou, P. G. Olsson, H. S. Maniar, P. Kjellén, J. D. Lambris, B. Christensson, L. Hammarström, D. Bentley, D. Vetrie, K. B. Islam, I. Vorechovsky, and P. Sideras. 1994. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J. Immunol. 152:557.
11. Hinshelwood, S., R. C. Lovering, H. C. Genevier, R. J. Levinsky, and C. Kinnon. 1995. The protein defective in X-linked agammaglobulinemia, Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross-linked. Eur. J. Immunol. 25: 1113.
12. De Weers, M., G. S. Brouns, S. Hinshelwood, C. Kinnon, R. K. B. Schuurman, R. W. Hendriks, and J. Borst. 1994. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J. Biol. Chem. 269:23857.
13. Matsuda, T., M. Takahashi-Tezuka, T. Fukada, Y. Okuyama, Y. Fujitani, S. Tsukada, H. Mono, H. Hirai, O. N. Witte, and T. Hirano. 1995. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines. Blood 85:627.
14. Kawakami, Y., L. Yao, T. Miura, S. Tsukada, O. N. Witte, and T. Kawakami. 1994. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon FcεRI cross-linking. Mol. Cell. Biol. 14:5108.
15. Li, T., S. Tsukada, A. Satterthwaite, M. H. Havlik, H. Park, K. Takatsu, and O. N. Witte. 1995. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2:451.
16. Cheng, G., Z.-S. Ye, and D. Baltimore. 1994. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc. Natl. Acad. Sci. USA 91:8152.
17. Koch, C. A., D. Anderson, M. F. Moran, C. Ellis, and T. Pawson. 1991. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252:668.
18. Yao, L., Y. Kawakami, and T. Kawakami. 1994. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc. Natl. Acad. Sci. USA 91:9175.
19. Tsukada, S., M. I. Simon, O. N. Witte, and A. Katz. 1994. Binding of βγ subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase. Proc. Natl. Acad. Sci. USA 91:11256.
20. Cory, G. O. C., R. C. Lovering, S. Hinshelwood, L. MacCarthy-Morrogh, R. J. Levinsky, and C. Kinnon. 1995. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J. Exp. Med. 182:611.
21. Derry, J. M. J., H. D. Ochs, and U. Francke. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78:635.
22. Rawlings, D. J., and O. N. Witte. 1995. The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation and function. Semin. Immunol. 7:237.
23. Pleiman, C. M., D. D'Ambrosio, and J. C. Cambier. 1994. The B-cell antigen receptor complex: structure and signal transduction. Immunol. Today 15:393.
24. Sato, K., H. Mano, T. Ariyama, J. Inazawa, Y. Yazaki, and H. Hirai. 1994. Molecular cloning and analysis of the human Tec protein-tyrosine kinase. Leukemia 8:1663.
25. Gibson, S., B. Leung, J. A. Squire, M. Hill, N. Arima, P. Goss, D. Hogg, and G. B. Mills. 1993. Identification, cloning and characterisation of a novel human T-cell-specific tyrosine kinase located at the hematopoietin complex on chromosome 5q. Blood 82:1561.
26. Frangioni, J. V., and B. G. Neel. 1993. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210:179.
27. Gout, I., R. Dhand, I. D. Hiles, M. J. Fry, G. Panayotou, P. Das, O. Truong, N. F. Totty, J. Hsuan, G. W. Booker, I. D. Campbell, and M. D. Waterfield. 1993. The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75:25.
28. Lau, Y. L., J. G. Shields, R. J. Levinsky, and R. E. Callard. 1989. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors. Clin. Exp. Immunol. 75:190.
29. Totty, N. F., M. D. Waterfield, and J. J. Hsuan. 1992. Accelerated high sensitivity microsequencing of proteins and peptides using a miniature reaction cartridge. Protein Sci. 1:1215.
30. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767.
31. Fukazawa, T., K. A. Reedquist, T. Trub, S. Soltoff, G. Panchamoorthy, B. Druker, L. Cantley, S. E. Shoelson, and H. Band. 1995. The SH3 domain-binding T cell tyrosyl phosphoprotein p120: demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J. Biol. Chem. 270:19141.
32. Lim, W. A., R. O. Fox, and F. M. Richards. 1994. Stability and peptide binding affinity of an SH3 domain from the Caenorhabditis elegans signaling protein Sem-5. Protein Sci. 3:1261.
33. + viruses but not for down-regulation of CD4. EMBO J. 14:484.
34. Rawlings, D. J., D. C. Saffran, S. Tsukada, D. A. Largaespada, J. C. Grimaldi, L. Cohen, R. N. Mohr, J. F. Bazan, M. Howard, N. G. Copeland, N. A. Jenkins, and O. N. Witte. 1993. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358.
35. Thomas, J. D., P. Sideras, C. I. E. Smith, I. Vorechovsky, V. Chapman, and W. E. Paul. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:355.